Pharma Industry News

Soleno’s drug misses key goal in Prader-Willi trial

The study failed to meet statistical significance for the primary endpoint, however, it did show a number of other significant benefitsOriginal Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]